U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Fermentative preparation process for and crystal forms of cytostatics

Patent 6380227 Issued on April 30, 2002. Estimated Expiration Date: Icon_subject September 7, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3459731

Water-soluble steroid compounds
Patent #: 4383992
Issued on: 05/17/1983
Inventor: Lipari

Water soluble cyclodextrin polymers substituted by ionic groups and process for the preparation thereof
Patent #: 4535152
Issued on: 08/13/1985
Inventor: Szejtli ,   et al.

Pharmaceutical composition and its nasal or vaginal use
Patent #: 4659696
Issued on: 04/21/1987
Inventor: Hirai ,   et al.

Method for treating taxol side-effects with G-CSF
Patent #: 5496804
Issued on: 03/05/1996
Inventor: Reed, et al.

Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
Patent #: 5565478
Issued on: 10/15/1996
Inventor: Kohn, et al.

Methods for administration of taxol
Patent #: 5641803
Issued on: 06/24/1997
Inventor: Carretta, et al.

Synthesis of epothilones, intermediates thereto, analogues and uses thereof Patent #: 6242469
Issued on: 06/05/2001
Inventor: Danishefsky ,   et al.

Inventor

Assignee

Application

No. 656954 filed on 09/07/2000

US Classes:

514/365, 1,3-thiazoles (including hydrogenated)435/118, Containing two or more hetero rings514/367, Bicyclo ring system having the thiazole ring as one of the cyclos514/450, The hetero ring has at least seven members546/340, The chalcogen, X, is in a -C(=X)- group548/204, The chalcogen, X, is in a -C(=X)- group548/510, The chalcogen, X, is in a -C(=X)- group548/567The nitrogen is bonded directly to -C(=X)-, wherein X is chalcogen (e.g., 2 benzamidomethyl - pyrrolidines, etc.)

Examiners

Primary: Lilling, Herbert J.

Attorney, Agent or Firm

Foreign Patent References

  • 1222697 CA. 06/11/1987
  • 31 182 18 DE. 04/11/1982
  • 33 170 64 DE. 11/11/1984
  • 33 461 23 DE. 06/11/1985
  • 41 38 042 DE. 05/11/1993
  • 42 07 922 DE. 09/11/1993
  • 0 094 157 EP. 11/11/1983
  • 0 149 197 EP. 07/11/1985
  • 0 197 571 EP. 10/11/1986
  • 0 091 781 EP. 11/11/1986
  • 0 292 050 EP. 11/11/1988
  • 0 300 526 EP. 01/11/1989
  • 0 320 032 EP. 06/11/1989
  • 0 396 184 EP. 11/11/1990
  • 0 499 322 EP. 08/11/1992
  • 0 503 710 EP. 09/11/1992
  • 0 636 634 EP. 02/11/1995
  • 0 818 469 EP. 01/11/1998
  • 2189245 GB. 10/11/1987
  • WO90/12035 WO. 10/11/1990
  • WO91/07967 WO. 06/11/1991
  • WO91/11200 WO. 08/11/1991
  • WO93/10121 WO. 05/11/1993
  • WO93/19061 WO. 09/11/1993
  • WO93/23017 WO. 11/11/1993
  • WO94/26728 WO. 11/11/1994
  • WO95/08993 WO. 04/11/1995
  • WO95/31178 WO. 11/11/1995
  • WO96/14090 WO. 05/11/1996
  • WO97/18839 WO. 05/11/1997
  • WO97/19086 WO. 05/11/1997
  • WO98/22461 WO. 05/11/1998
  • WO98/25929 WO. 06/11/1998
  • WO99/01124 WO. 01/11/1999
  • WO99/65913 WO. 12/11/1999

International Classes

C12P 017/16
A61K 031/365
A61K 031/427

Foreign Application Priority Data

1998-02-19 CH

Abstract

The invention relates to a new process for concentrating epothilones in culture media, a new process for the production of epothilones, a new process for separating epothilones A and B and a new strain obtained by mutagenesis for the production of epothilones, as well as aspects related thereto. New crystal forms of epothilone B are also described.

Other References

  • Bollag et al., Cancer Research, vol. 55, pp. 2325-2333 (1995)
  • Chemical Abstracts 98:124208s, Koho, JP 57,194,787, Nov. 30, 1982
  • Chemical Abstracts 96:223270w, Koho, JP 8,224,312, Jan. 30, 1982
  • Gerth et al., The Journal of Antibiotics, vol. 49, No. 6, pp. 560-562 (1996)
  • Hoefle et al., Angew. Chem., vol. 108, No.13/14, pp. 1671-1673 (1996)
  • Horikoshi, Chemical Economy & Engineering Review, vol, 13, No,. 1-2 (140-145) pp 7-11 (1981)
  • Loftsson et al., Journal of Pharmaceutical Sciences, vol. 85, No. 10, pp. 1017-1025
  • May, Scott et al., Chem. Commun. Total sysnthesis of (-) epothilone B, pp. 1597-1598 (1998)
  • Meng et al., J. Am Chem. Soc., vol. 119, pp. 10073-10092 (1997)
  • Nicolaou et al., J. Am. Chem. Soc., vol. 119, pp. 7974-7991 (1997)
  • Nicolaou et al., Nature, vol. 387, pp. 268-272 (1997)
  • Rajewski et al., Journal of Pharmaceutical Science, vol. 85, No. 11, pp. 1142-1169 (1996)
  • Rowinski, Ann. Rev. Med., vol. 48, pp. 353-374 (1997)
  • Hofle et al., Angew. Chem. Int. Ed. Engl., vol. 35 (13/14), "Epothilone A and B--Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution," pp. 1567-1569 (1996
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?